文献速递心脑血管急症

瑞典近期急性心肌梗死接受抗血栓治疗患者缺血与出血事件与死亡率的关联

Association of Ischemic and Bleeding Events With Mortality Among Patients in Sweden With Recent Acute Myocardial Infarction Receiving Antithrombotic Therapy.
PubMed 文献 · JAMA Netw Open · 2022-08-01
一句话结论近期心梗出院后,缺血事件比出血事件更常见且与更高死亡率相关(aHR 1.27),支持个体化抗血栓治疗时重视缺血风险。

该研究基于瑞典全国登记数据,纳入2012-2017年心梗出院后存活并接受抗血栓治疗(抗血小板或口服抗凝)的86 736例患者(中位年龄71岁,66.0%男性)。随访至出院后1年,首次缺血事件发生率为5.7/100人年,首次出血事件为4.8/100人年;缺血事件后死亡率为46.2/100人年,出血事件后为27.1/100人年。与无事件相比,缺血事件后1年死亡aHR为4.16(95%CI 3.91-4.43),出血事件后为3.43(95%CI 3.17-3.71);缺血 vs 出血事件的aHR为1.27(95%CI 1.15-1.40)。1997-2000、2001-2011和2012-2017三个出院时期中,缺血 vs 出血事件的aHR无统计学显著差异。

要点

  • 心梗出院后1年内,缺血事件(心梗或缺血性卒中住院)发生率5.7/100人年,高于出血事件(出血住院)的4.8/100人年。
  • 缺血事件后1年死亡率为46.2/100人年,出血事件后为27.1/100人年。
  • 与无事件相比,缺血事件后1年死亡aHR 4.16(95%CI 3.91-4.43),出血事件后aHR 3.43(95%CI 3.17-3.71)。
  • 缺血 vs 出血事件的1年死亡aHR为1.27(95%CI 1.15-1.40),缺血事件与更高死亡风险相关。
  • 1997-2000、2001-2011和2012-2017三个时期,缺血 vs 出血事件的aHR无统计学显著差异。

适用人群与场景

  • 2012-2017年瑞典全国登记中,心梗出院后存活并接受抗血栓治疗(抗血小板治疗或口服抗凝)的患者,共86 736例(中位年龄71岁,IQR 62-80岁;57 287例[66.0%]男性)。

研究设计与关键结果

  • 研究类型:基于瑞典全国登记(2012-2017年)的队列研究;数据分析于2021年7月至2022年5月进行。
  • 纳入86 736例心梗出院后存活并接受抗血栓治疗的患者,中位年龄71岁(IQR 62-80),57 287例(66.0%)为男性。
  • 出院后1年内,4039例发生首次缺血事件(5.7/100人年),3399例发生首次出血事件(4.8/100人年)。
  • 缺血事件后死亡率为46.2/100人年,出血事件后为27.1/100人年。
  • 与无事件相比,1年死亡aHR:缺血事件后4.16(95%CI 3.91-4.43),出血事件后3.43(95%CI 3.17-3.71)。
  • 缺血 vs 出血事件的1年死亡aHR为1.27(95%CI 1.15-1.40)。
  • 1997-2000、2001-2011和2012-2017三个出院时期中,缺血 vs 出血事件的aHR无统计学显著差异。

证据类型、等级与局限

  • 证据类型:基于全国登记的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在心梗后接受抗血栓治疗的患者中,出院后缺血事件比出血事件更常见,且与更高的死亡风险相关;原文未据此给出具体推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Antithrombotic treatment after myocardial infarction (MI) should be individualized based on the patient's risk of ischemic and bleeding events. Uncertainty remains regarding the relative prognostic importance of the 2 types of events, and further study would be useful.

OBJECTIVES: To compare the association of ischemic vs bleeding events with mortality in patients with a recent MI and assess whether the relative mortality risk for the 2 types of events has changed over the past 2 decades.

DESIGN, SETTING, AND PARTICIPANTS: A cohort study based on nationwide registers in Sweden, 2012-2017, was conducted. Data were analyzed between July 2021 and May 2022. Patients with MI who were discharged alive with antithrombotic therapy (antiplatelet therapy or oral anticoagulation) were included in the analysis.

MAIN OUTCOMES AND MEASURES: The incidence of a first ischemic event (hospitalization for MI or ischemic stroke) or bleeding event (hospitalization with bleeding) up to 1 year after discharge and the mortality risk up to 1 year after each type of event were assessed. Cox proportional hazards regression models were used to estimate adjusted hazard ratios (aHRs) for 1-year mortality after an ischemic and bleeding event vs no event, and after an ischemic vs bleeding event. Adjusted HRs for mortality after ischemic vs bleeding events were compared among patients discharged in 1997-2000, 2001-2011, and 2012-2017.

RESULTS: Of 86 736 patients discharged after MI in 2012-2017 (median age, 71 [IQR, 62-80] years; 57 287 [66.0%] men), 4039 individuals experienced a first ischemic event (5.7 per 100 person-years) and 3399 experienced a first bleeding event (4.8 per 100 person-years). The mortality rate was 46.2 per 100 person-years after an ischemic event and 27.1 per 100 person-years after a bleeding event. The aHR for 1-year mortality vs no event was 4.16 (95% CI, 3.91-4.43) after an ischemic event and 3.43 (95% CI, 3.17-3.71) after a bleeding event. When the 2 types of events were compared, the aHR was 1.27 (95% CI, 1.15-1.40) for an ischemic vs bleeding event. There was no statistically significant difference in the aHR of an ischemic vs bleeding event in 1997-2000, 2001-2011, and 2012-2017.

CONCLUSIONS AND RELEVANCE: In this nationwide cohort study of patients with a recent MI, postdischarge ischemic events were more common and associated with higher mortality risk compared with bleeding events.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Simonsson M, Alfredsson J, Szummer K, et al. Association of Ischemic and Bleeding Events With Mortality Among Patients in Sweden With Recent Acute Myocardial Infarction Receiving Antithrombotic Therapy. JAMA Netw Open. 2022. PMID: 36036452. doi:10.1001/jamanetworkopen.2022.20030

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。